A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride.
Maryam Razzaghy-AzarMitra NourbakhshMona NourbakhshPublished in: Clinical endocrinology (2018)
CyproH caused height growth in the patients with GHIS, and therefore, this treatment can be considered as an alternative option to IGF-I injection.